Cargando…
Target c-Myc to treat pancreatic cancer
C-Myc overexpression is a common finding in pancreatic cancer and predicts the aggressive behavior of cancer cells. It binds to the promoter of different genes, thereby regulating their transcription. C-Myc is downstream of KRAS and interacts with several oncogenic and proliferative pathways in panc...
Autor principal: | Ala, Moein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812741/ https://www.ncbi.nlm.nih.gov/pubmed/34978469 http://dx.doi.org/10.1080/15384047.2021.2017223 |
Ejemplares similares
-
Rationale for MYC imaging and targeting in pancreatic cancer
por: Schneider, Günter, et al.
Publicado: (2021) -
G-Quadruplexes in c-MYC Promoter as Targets for Cancer Therapy
por: Bahls, Bárbara, et al.
Publicado: (2023) -
Strategically targeting MYC in cancer
por: Posternak, Valeriya, et al.
Publicado: (2016) -
Sestrin2 in cancer: a foe or a friend?
por: Ala, Moein
Publicado: (2022) -
Small Molecules Targeting c-Myc Oncogene: Promising Anti-Cancer Therapeutics
por: Chen, Bing-Jia, et al.
Publicado: (2014)